Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Clareo Health | Breast Cancer Clinical Trials in Illinois | 1,017 Studies

Clinical Trials Breast CancerIllinois

Breast Cancer Clinical Trials in Illinois

Find 1,017 clinical trials for breast cancer near Illinois. Connect with research centers in your area.

All Breast Cancer trials nationwide All trials in Illinois

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4Not applicable

Who can join

Healthy volunteers too

Showing 481-500 of 1,017 trials

TerminatedStudy of Denosumab as Adjuvant Treatment for Women With High Risk Early Breast Cancer Receiving Neoadjuvant or Adjuvant Therapy (D-CARE)This randomized phase 3 trial is studying the effect of denosumab to see if it can prevent disease recurrence in the bone or in any other part of the body, when it is given as…NCT01077154·Birmingham, Alabama and 458 others

Breast Cancer Trials in Other Cities

New York Los Angeles Chicago Houston Phoenix Philadelphia

Data from ClinicalTrials.govTerms

RecruitingStudy of Sacituzumab Govitecan-hziy and Pembrolizumab Versus Treatment of Physician's Choice in Patients With Triple Negative Breast Cancer Who Have Residual Invasive Disease After Surgery and Neoadjuvant Therapy (ASCENT-05/AFT-65 OptimICE-RD/GBG 119/NSABP B-63)The goal of this study is to find out if the experimental product, sacituzumab govitecan-hziy (SG) in combination with pembrolizumab given after surgery, is effective and safe…NCT05633654·Birmingham, Alabama and 377 others

Active not recruitingSacituzumab Govitecan +/- Pembrolizumab In HR+ / HER2 - MBCThis research study is evaluating the safety and effectiveness of Sacituzumab Govitecan with or without Pembrolizumab in metastatic HR+/HER2- breast cancer.NCT04448886·Atlanta, Georgia and 7 others

CompletedPalbociclib in Combination With Tamoxifen as First Line Therapy for Metastatic Hormone Receptor Positive Breast CancerThis is a non-randomized, open-label, single-arm, multicenter, phase II study of palbociclib in combination with tamoxifen in women with HR(+)/HER2(-) advanced breast cancer who…NCT02668666·Chicago, Illinois and 6 others

CompletedDoxorubicin Hydrochloride, Cyclophosphamide, and Pacltaxel With or Without Trastuzumab in Treating Women With HER2-Positive Node-Positive or High-Risk Node-Negative Breast CancerThis randomized phase III trial studies doxorubicin hydrochloride, cyclophosphamide, paclitaxel, and trastuzumab to see how well they work compared to combination chemotherapy…NCT00005970·Birmingham, Alabama and 156 others

CompletedTamoxifen Compared With LY353381 in Treating Women With Newly Diagnosed Breast CancerRATIONALE: Estrogen can stimulate the growth of breast cancer cells. Hormone therapy using tamoxifen or LY353381 may fight breast cancer by blocking the use of estrogen.NCT00005886·Birmingham, Alabama and 8 others

Active not recruitingThe Hurria Older PatiEnts (HOPE) With Breast Cancer StudyThe goal of this study is to develop a "bedside to bench" model of clinical and biological predictors for toxicity to adjuvant and neoadjuvant chemotherapy in older adults with…NCT01472094·Duarte, California and 16 others

CompletedImetelstat in Combination With Paclitaxel (With or Without Bevacizumab) in Patients With Locally Recurrent or Metastatic Breast CancerThe purpose of this study is to evaluate the efficacy and safety of treatment with imetelstat + paclitaxel (with or without bevacizumab) versus paclitaxel (with or without…NCT01256762·Huntsville, Alabama and 54 others

WithdrawnPartial Breast Irradiation in a Low-risk Population Screened With MRIThis is a pilot study to determine if partial breast irradiation (PBI) limited to the region of the tumor bed following lumpectomy in patients screened with MRI provides…NCT01255553·Chicago, Illinois

CompletedPrognostic Study of Sentinel Lymph Node and Bone Marrow Metastases in Women With Stage I or Stage IIA Breast CancerRATIONALE: Biopsy of sentinel lymph nodes and bone marrow may improve the ability to detect and determine the extent of cancer.NCT00003854·Birmingham, Alabama and 115 others

CompletedAnalyzing a New Mechanism in Response to Tamoxifen Therapy in Breast Cancer PatientsThis study will help to understand the interaction between estrogen receptor-alpha (ER alpha) and tumor suppressor protein p53 as well as impact on patient tumor gene expression…NCT01027416·Chicago, Illinois and 1 other

CompletedStudy to Assess the Safety and Efficacy of Ribociclib (LEE011) in Combination With Letrozole for the Treatment of Men and Pre/Postmenopausal Women With HR+ HER2- aBCThe purpose of this study is to collect additional safety and efficacy data for the combination of ribociclib + letrozole in men and pre/postmenopausal women with HR+HER2-…NCT02941926·Anchorage, Alaska and 494 others

UnknownA Prospective Study of Breast Cancer Patients With Abnormal Strain ImagingThe Cardio-Oncology program at Northwestern offers care to cancer patients who develop cardiac toxicities from chemotherapy.NCT02993198·Chicago, Illinois

CompletedDS-8201a in Pre-treated HER2 Breast Cancer That Cannot be Surgically Removed or Has Spread [DESTINY-Breast02]This study will compare DS 8201a to standard treatment. Participants must have HER2 breast cancer that has been treated before.NCT03523585·Chandler, Arizona and 226 others

CompletedA Study With ABBV-155 Alone and in Combination With Taxane Therapy in Adults With Relapsed and/or Refractory Solid TumorsAn open-label, dose-escalation (Part 1), dose-expansion (Part 2) study to assess the safety, pharmacokinetics (PK), and preliminary efficacy of ABBV-155 alone and in combination…NCT03595059·Birmingham, Alabama and 39 others

Active not recruitingA Study Evaluating the Efficacy and Safety of Adjuvant Giredestrant Compared With Physician's Choice of Adjuvant Endocrine Monotherapy in Participants With Estrogen Receptor-Positive, HER2-Negative Early Breast Cancer (lidERA Breast Cancer)This is a Phase III, global, randomized, open-label, multicenter, study evaluating the efficacy and safety of adjuvant giredestrant compared with physician's choice of endocrine…NCT04961996·Daphne, Alabama and 620 others

Active not recruitingOptimizing a mHealth Physical Activity Intervention With Mindful Awareness Lessons in Breast Cancer SurvivorsThe primary purpose of the present study is to apply MOST methodology to determine which types of social support and mindfulness training intervention components optimally…NCT05931874·Chicago, Illinois

CompletedAn Investigational Drug (CAL) Versus Zoledronic Acid (Zometa®) in Patients With Breast CancerThis study is intended to evaluate the safety, tolerability, and possible effectiveness of an investigational humanized monoclonal antibody (CAL) to the parathyroid…NCT00051779·Little Rock, Arkansas and 37 others

CompletedCyclosporine A in Combination With Nab-Paclitaxel in Patients With Metastatic Breast CancerThe purpose of this research study is to evaluate the safety of therapy with nab-paclitaxel and CsA and if the addition of Cyclosporine A (CsA) to nab-paclitaxel helps stop cancer…NCT00983424·Chicago, Illinois

Active not recruitingBreast Cancer WEight Loss Study (BWEL Study)This randomized phase III trial compares whether weight loss in overweight and obese women may prevent breast cancer from coming back (recurrence).NCT02750826·Daphne, Alabama and 1497 others

PreviousPage 25 of 51Next

Other Conditions in Illinois

Lung Cancer Prostate Cancer Colorectal Cancer Melanoma Leukemia Lymphoma